Group B streptococcal infection medical therapy: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 9: | Line 9: | ||
GBS should be suspected as a causative agent for bacterial meningitis in infants less than two years of age for whom empirical antibiotic therapy should be initiated immediately. | GBS should be suspected as a causative agent for bacterial meningitis in infants less than two years of age for whom empirical antibiotic therapy should be initiated immediately. | ||
{| | {| style="cellpadding=0; cellspacing= 0; width: 800px;" | ||
|- | |- | ||
| 1-23 months ||[[Streptococcus pneumoniae]] <br> [[Neisseria meningitidis]] <br> [[Streptococcus agalactiae]] <br> [[Haemophilus influenzae]] <br> [[E. coli]]|| [[Vancomycin]] + third generation [[cephalosporin]] | | style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center | '''Age''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center |'''Possible pathogens causing the bacterial meningitis'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center |'''Empirical treatment''' | ||
|- | |||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |< 1 month ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Streptococcus agalactiae]] <br> [[Escherichia coli]] <br> [[Listeria monocytogenes]] <br> [[Klebsiella]]|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Ampicillin]] + [[cefotaxime]] <br> OR <br> [[Ampicillin]] + [[aminoglycoside]] | |||
|- | |||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1-23 months ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Streptococcus pneumoniae]] <br> [[Neisseria meningitidis]] <br> [[Streptococcus agalactiae]] <br> [[Haemophilus influenzae]] <br> [[E. coli]]|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Vancomycin]] + third generation [[cephalosporin]] | |||
|- | |- | ||
|} | |} | ||
Revision as of 21:29, 19 August 2014
|
Group B Streptococcal Infection Microchapters |
|
Differentiating Group B Streptococcal Infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Group B streptococcal infection medical therapy On the Web |
|
American Roentgen Ray Society Images of Group B streptococcal infection medical therapy |
|
Directions to Hospitals Treating Group B streptococcal infection |
|
Risk calculators and risk factors for Group B streptococcal infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Medical Therapy
Empirical Antibiotic Therapy in Neonatal Meningitis
GBS should be suspected as a causative agent for bacterial meningitis in infants less than two years of age for whom empirical antibiotic therapy should be initiated immediately.
| Age | Possible pathogens causing the bacterial meningitis | Empirical treatment |
| < 1 month | Streptococcus agalactiae Escherichia coli Listeria monocytogenes Klebsiella |
Ampicillin + cefotaxime OR Ampicillin + aminoglycoside |
| 1-23 months | Streptococcus pneumoniae Neisseria meningitidis Streptococcus agalactiae Haemophilus influenzae E. coli |
Vancomycin + third generation cephalosporin |